Activation of p53 DNA binding activity by point mutation

Oncogene

Volumn 16, Issue 24, 1998, Pages 3123-3131

  Marston, Nicola J ^a,b   Ludwig, Robert L ^a   Vousden, Karen H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Apoptosis; Cell cycle arrest; DNA binding; p53

Indexed keywords

LYSINE; PROTEIN P53;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CONFORMATIONAL TRANSITION; DELETION MUTANT; DNA BINDING; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL;

EID: 0032543608     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201856     Document Type: Article

References (50)

1. Abarzúa P. LoSardo JE, Gubler ML and Neri A. (1995). Cancer Res., 55, 3490-3494.
2. Abarzúa P, LoSardo JE, Gubler ML, Spathis R, Lu Y-A, Felix A and Neri A. (1996). Oncogene, 13, 2477-2482.
3. Anderson ME, Woelker B, Reed M, Wang P and Tegtmeyer P. (1997). Mol. Cell. Biol., 17, 6255-6264.
4. Attardi LD, Lowe SW, Brugarolas J and Jacks T. (1996). EMBO J., 15, 3639-3701.
5. Banks L, Matlashewski G and Crawford L. (1986). Eur. J. Biochem., 159, 529-534.
6. Bates S and Vousden KH. (1996) Current Opin. Genet. Dev., 6, 1-7.
7. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ. (1995). Nature, 377, 552-556.
8. Caelles C, Helmberg A and Karin M. (1994). Nature, 370, 220-223.
9. Crook T, Ludwig RL, Marston NJ, Willkomm D and Vousden KH. (1996). Virol., 217, 285-292.
10. Crook T, Marston NJ, Sara EA and Vousden KH. (1994). Cell, 79, 817-827.
11. Deng C, Zhang P, Harper JW, Elledge SJ and Leder P. (1995). Cell, 82, 675-684.
12. El-Deiry W, Tokino T, Velculescu VE, Levy DB, Parson VE, Trent JM, Lin D., Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
13. Fredersdorf S, Milne AW, Hall PA and Lu X. (1996). Am. J. Pathol., 148, 825-835.
14. Freidlander P, Haupt Y, Prives C and Oren M. (1996). Mol. Cell. Biol., 16, 4961-4971.
15. Gorospe M, Cirielli C, Wamg X, Seth P, Capogrossi MC and Holbrook NJ. (1997). Oncogene, 14, 929-935.
16. Gu W and Roeder RG. (1997). Cell, 90, 595-606.
17. Hainault P and Milner J. (1993). Cancer Res., 53, 4469-4473.
18. Halazonetis TD, Davis LJ and Kandil AN. (1993). EMBO J., 12, 1021-1028.
19. Halazonetis TD and Kandil AN. (1993). EMBO J., 12, 5057-5064.
20. Haupt Y, Maya R, Kazaz A and Oren M. (1997). Nature, 387, 296-299.
21. Haupt Y, Rowan S, Shaulian E, Vousden KH and Oren M. (1995). Genes and Dev., 9, 2170-2183.
22. Hollstein M, Rice K, Greenhlatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC. (1994). Nuc. Acids Res., 22, 3551-3555.
23. Hupp TR and Lan DP. (1994). CSH Symp. Quant. Biol., 59, 195-206.
24. Hupp TR and Lane DP. (1995). J. Biol. Chem., 270, 18165-18174.
25. Hupp TR, Meek DW, Midgley CA and Lane DP. (1992). Cell, 71, 875-886.
26. Hupp TR, Sparks A and Lane DP. (1995). Cell, 83, 237-245.
27. Jayaraman L, Murthy KGK, Zhu C, Curran T, Xanthoudakis S and Prives C. (1997). Genes and Dev., 11, 558-570.
28. Jayaraman L and Prives C. (1995). Cell, 81, 1021-1029.
29. Juven T, Barak Y, Zauberman A, George DL and Oren M. (1993). Oncogene, 8, 3411-3416.
30. Kubbutat MHG, Jones SN and Vousden KH. (1997). Nature, 387, 299-303.
31. Lam EWF and Watson RJ. (1993). EMBO J., 12, 2705-2713.
32. Lane DP. (1992). Nature, 358, 15-16.
33. Lu X, Burbridge SA, Girffin S and Smith HM. (1997). Oncogene, 13, 413-418.
34. Ludwig RL, Bates S and Vousden KH. (1996). Mol. Cell. Biol., 16, 4952-4960.
35. Lutzker SG and Levine AJ. (1996). Nature Med., 2, 804-810.
36. Marston NJ, Crook T and Vousden KH. (1994). Oncogene, 9, 2707-2716.
37. Marston NJ, Jenkins JR and Vousden KH. (1995). Oncogene, 10, 1709-1715.
38. Miyashita T and Reed JC. (1995). Cell, 80, 293-299.
39. Renzing J and Lane DP. (1995). Oncogene, 10, 1865-1868.
40. Rowan S, Ludwig RL, Haupt Y, Bates S, Lu X, Oren M and Vousden KH. (1996). EMBO J., 15, 827-838.
41. Sabbalini P, Lin J, Levine AJ and White E. (1995). Genes and Dev., 9, 2184-2192.
42. Selivanova G, Iotsova V, Okan I, Fritsche M, Ström M, Groner B., Grafström RC and Wiman KG. (1997). Nature Med., 3, 632-638.
43. Shaw P, Freeman J, Bovey R and Iggo R. (1996). Oncogene, 12, 921-930.
44. Sun Y, Bian J, Wang Y and Jacobs C. (1997). Oncogene, 14, 385-393.
45. Tarunina M and Jenkins JR. (1993). Oncogene, 7, 3165-3173.
46. Vojtesek B, Bartek J, Midgley CA and Lane DP. (1992). J. Immunol. Meth., 151, 237-244.
47. Wade-Evans A and Jenkins JR. (1985). EMBO J., 4, 699-706.
48. Waldman T, Kinzler KW and Vogelstein B. (1995). Cancer Res., 55, 5187-5190.
49. Wang Y and Prives C. (1995). Nature, 376, 88-91.
50. Weinberg WC, Azzoli CG, Chapman K, Levine AJ and Yuspa SH. (1995). Oncogene, 10, 2271-2279.